Marshall Wace North America’s Wave Life Sciences WVE Stock Holding History

Marshall Wace North America’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-90,102	Closed	-$505K	–	1835
2021 Q1	$505K	Buy	+90,102	New	+$866K	﹤0.01%	1195
2020 Q4	–	Sell	-36,762	Closed	-$313K	–	1621
2020 Q3	$313K	Buy	+36,762	New	+$403K	﹤0.01%	1062
2019 Q4	–	Sell	-59,356	Closed	-$1.22M	–	1648
2019 Q3	$1.22M	Buy	+59,356	New	+$1.36M	0.01%	649
2019 Q2	–	Sell	-220,321	Closed	-$8.56M	–	1667
2019 Q1	$8.56M	Buy	+220,321	New	+$8.94M	0.06%	229
2017 Q4	–	Sell	-61,286	Closed	-$1.35M	–	1642
2017 Q3	$1.35M	Hold	61,286	–	–	0.01%	889
2017 Q2	$1.16M	Buy	61,286 +31,464	+106%	+$678K	0.01%	900
2017 Q1	$835K	Buy	+29,822	New	+$833K	0.01%	733

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Marshall Wace North America's WVE Position: Q2 2021 in Review

Marshall Wace North America sold out of Wave Life Sciences (WVE) in Q2 2021, closing a stake of 90,102 shares — an estimated $505K sold.

Marshall Wace North America first reported a position in WVE in Q1 2017 and held it in 7 quarters. The position peaked at $8.56M in Q1 2019. 87 funds tracked by Wall St. Rank hold WVE as of Q2 2021.

Marshall Wace North America reported no remaining Wave Life Sciences position as of Q2 2021 after selling out during the quarter.
Marshall Wace North America sold 90,102 Wave Life Sciences shares in Q2 2021, an estimated $505K.
Marshall Wace North America first reported a position in Wave Life Sciences in Q1 2017 and held it in 7 quarters.
Marshall Wace North America's Wave Life Sciences position peaked at $8.56M in Q1 2019.
87 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2021.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.